Google DeepMind unveils AI model predicting genetic variant effects on cells
The tool is a new version of DeepMind's AlphaGenome system, and it is aimed at research use rather than public release.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Google DeepMind has unveiled AlphaGenome 2, an AI model designed to predict how genetic variants affect specific cell types and states. It was trained on more than 100 million cell profiles across 68 tissues. Genomics Limited plans to add it to its Mystra platform, letting drugmakers estimate which genes a DNA variant affects and in which cells before deciding what to test.
Why it matters
Google says it is available for research only.
Timeline
- Nov 11, 12:24 PM ET: Google DeepMind unveiled AlphaGenome 2, an AI model that predicts how genetic variants affect specific cell types and states.
- Nov 12, 4:39 AM ET: Genomics Limited plans to add AlphaGenome 2 to its Mystra platform so drugmakers can predict which genes a DNA variant affects and in which cells.
Coverage
- Google’s new AI reveals hidden genetic clues in new immune-cell test (Liam 'Akiba' Wright)
- AlphaGenome 2: 100M+ Cell Profiles, 68 Tissues [2026] (shattered.io)
- 😺 DeepMind launched AlphaGenome 2 for DNA (Eric Gerard Ruiz)
- DeepMind’s AlphaGenome 2 Could Help Pharma Find Drug Targets Hidden in DNA (Amit Raja Naik)
- Sundar Pichai Says ‘Every Cell In Our Body Shares the Same DNA Blueprint’ as Google DeepMind Unveils… (benzinga.com)
- AI Identifies Disease Clues in 30 Minutes (Choi Won-woo)
More from Technology & AI
- China puts humanoid robots to work serving food and sorting parcels
- Newsom proposes sweeping AI safety rules for Washington
- Google releases Gemini 4 Neon AI model with million-token context
- Microsoft and Intel widen their cloud chip partnership
- Google DeepMind rolls out Genie 4 to select subscribers
- AI helped AMD shorten chip design work, OpenAI says